Transcription factors in myeloid development: balancing differentiation with transformation
The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.
Abstract
In recent years, great progress has been made in elucidating the progenitor-cell hierarchy of the myeloid lineage. Transcription factors have been shown to be key determinants in the orchestration of myeloid identity and differentiation fates. Most transcription factors show cell-lineage-restricted and stage-restricted expression patterns, indicating the requirement for tight regulation of their activities. Moreover, if dysregulated or mutated, these transcription factors cause the differentiation block observed in many myeloid leukaemias. Consequently, therapies designed to restore defective transcription factor functions are an attractive option in the treatment of myeloid and other human cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, downregulation of PU.1 was identified as a mechanism for the induction of leukemias generated by PML-RARa, FLT3-ITD, and AML1-ETO.[43][44][45]”
From USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism (2018) · cites this paper as [43]
In the citing paper
“PU.1, a non-canonical pioneer transcription factor that functions as a master regulator of myeloid and lymphoid lineage differentiation18–20.”
From Lymphoid gene expression supports neuroprotective microglia function (2025) · cites this paper as [18]
In the citing paper
“Irf8 promotes GM lineage differentiation.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“In particular, Irf8 promotes monocyte differentiation as a lineage switch between monocyte and granulocyte bifurcation29.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“All activated macrophages, regardless of polarization state, express high levels of the transcription factors runt-related transcription factor 1 (RUNX1) and PU.1, which are thought to represent global regulators of macrophage phenotypic expression [20–22].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [20]
Citations
Cites
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617 · cited 1×
“The first lymphoid progenitor population that is known to arise from MPPs is the common lymphoid progenitors (CLPs; LIN − IL-7Rα + SCA1 low KIT low”
BackgroundIdentification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Differentiation and proliferation of hematopoietic stem cells
Ogawa, M. (1993) · Blood · doi:10.1182/blood.v81.11.2844.2844 · Cited by 1,383
Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L. A. M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,236
Oncogenic Transcription Factors in the Human Acute Leukemias
Look, A. T. (1997) · Science · doi:10.1126/science.278.5340.1059 · Cited by 1,187
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells
Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano, A., & Geissmann, F. (2006) · Science · doi:10.1126/science.1117729 · Cited by 1,053
Research works printed but not linked: 1
- Iwasaki, H. et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590–1600 (2005). · DOI · Paper page
Cited by
Items 401–500 of 608
Noncoding RNAs in Acute Myeloid Leukemia: From Key Regulators to Clinical Players
Fatica, A. (2012) · Scientifica · doi:10.6064/2012/925758 · Cited by 11
A STATus report on DC development
Li, H. S., & Watowich, S. S. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212052 · Cited by 12
Brien, G. L., & Bracken, A. P. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.07.010 · Cited by 11
“[2] Rosenbauer F, Tenen DG.”
Forward programming human pluripotent stem cells into microglia
Csatári, J., Wiendl, H., & Pawlowski, M. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.03.006 · Cited by 11
Schell, B., Zhao, L., M'Sibih, I., Kalogeraki, M., Kergaravat, C., Lereclus, E., Fenaux, P., Adès, L., Toubert, A., Espéli, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-07717-9 · Cited by 13
Proteomic approaches in myeloid leukemia
Kanaujiya, J. K., Lochab, S., Pal, P., Christopeit, M., Singh, S. M., Sanyal, S., Behre, G., & Trivedi, A. K. (2011) · Electrophoresis · doi:10.1002/elps.201000428 · Cited by 9
LPS independent activation of the pro-inflammatory receptor Trem1 by C/EBPε in granulocytes
Suh, H. C., Benoukraf, T., Shyamsunder, P., Tong, Y., Cao, Q., Said, J. W., Lee, S., Lim, R., Yang, H. H., Salotti, J., et al. (2017) · Scientific Reports · doi:10.1038/srep46440 · Cited by 11
Sioud, M. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12957 · Cited by 9
TC1(C8orf4) Regulates Hematopoietic Stem/Progenitor Cells and Hematopoiesis
Jung, Y., Kim, M., Soh, H., Lee, S., Kim, J., Park, S., Song, K., & Lee, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100311 · Cited by 10
“We first investigated the expression of major transcriptional regulators for myelopoiesis [25].”
BackgroundRole of microRNAs in haemopoiesis, heart hypertrophy and cancer
Fontana, L., Sorrentino, A., Condorelli, G., & Peschle, C. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361206 · Cited by 9
Wilson, N. K., Tijssen, M. R., & Göttgens, B. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.07.005 · Cited by 9
“Moreover, acquired mutations involving TF genes represent a recurrent theme in many leukemias [9], suggesting that careful control of TF activity is essential for normal hematopoietic function as well as preventing development of hematological malignancies.”
BackgroundDuggan, J. M., Buechler, M. B., Olson, R. M., Hohl, T. M., & Hamerman, J. A. (2017) · Blood · doi:10.1182/blood-2016-06-719823 · Cited by 11
Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations
Volpe, G., Cauchy, P., Walton, D. S., Ward, C., Blakemore, D., Bayley, R., Clarke, M. L., Schmidt, L., Nerlov, C., García, P., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201800207 · Cited by 10
“…collaboration between mutations affecting transcription factors (e.g., CEBPA, PU.1, and RUNX1) and signalling proteins (such as FLT3, RAS, and KIT) that lead to an aberrant proliferation capacity coupled with a disruption of terminal myeloid differentiation (Tenen, 2003; Rosenbauer & Tenen, 2007).”
Palau, A., Segerberg, F., Lidschreiber, M., Lidschreiber, K., Naughton, A., Needhamsen, M., Jung, L. A., Jagodic, M., Cramer, P., Lehmann, S., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01972-3 · Cited by 9
“The myeloid differentiation is tightly orchestrated by a network of transcription factors that are essential for complete cell maturation [42].”
BackgroundNeutrophil Spatiotemporal Regulatory Networks: Dual Roles in Tumor Growth Regulation and Metastasis
Li, P., Fan, F., Zhang, B., Yuan, C., & Liang, H. (2025) · Biomedicines · doi:10.3390/biomedicines13061473 · Cited by 10
Bartel, Y., Grez, M., & Wichmann, C. W. (2013) · BioMed Research International · doi:10.1155/2013/297692 · Cited by 16
“Most often, the affected proteins are transcription factors regulating critical steps during hematopoiesis [2].”
BackgroundTRAPPC1 is essential for the maintenance and differentiation of common myeloid progenitors in mice
Xu, Y., Zhang, Z., Zhao, Y., Zhao, C., Shi, M., Dong, X., Zhang, J., Tan, L., Zhang, L., & Zhao, Y. X. (2022) · EMBO Reports · doi:10.15252/embr.202255503 · Cited by 8
“…protein alpha (C/EBP a ), and Ruppel-like factor 5, are essential for the progression of multipotent progenitors to monocytes/macrophages and neutrophils, although they may act in the bone marrow at different development stages (Zhang et al , 1997; Rosenbauer & Tenen, 2007; Shahrin et al , 2016).”
Trapping of transcription factors with symmetrical DNA using thiol-disulfide exchange chemistry
Panda, M., Jiang, D., & Jarrett, H. W. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.06.020 · Cited by 8
Lieber, S., Scheer, F. M., Finkernagel, F., Meißner, W., Giehl, G., Brendel, C. A., Diederich, W. E., Müller‐Brüsselbach, S., & Müller, R. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094672 · Cited by 8
“Myeloid differentiation is governed by several key transcription factors (Rosenbauer and Tenen, 2007).”
BackgroundViryasova, G. M., Golenkina, E. A., Tatarskiy, V. V., Galkin, I. I., Sud’ina, G. F., & Soshnikova, N. V. (2019) · MethodsX · doi:10.1016/j.mex.2019.02.011 · Cited by 7
“GFI1 promotes differentiation in myeloid cells and is crucial for late-stage neutrophil production [9].”
BackgroundNie, Y., Su, L., Li, W., & Gao, S. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103379 · Cited by 10
N6-Methyladenosine RNA Modification in Normal and Malignant Hematopoiesis
Weng, H., Huang, H., & Chen, J. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-7471-9_7 · Cited by 7
Wang, H. C., Chen, R., Yang, W., Li, Y., Muthukumar, R., Patel, R. M., Casey, E. B., Denby, E., & Magee, J. A. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114542 · Cited by 7
“57,58 G-CSF suppressed Irf8 expression and promoted Gfi1 expression, but the changes were similar in both wild-type and Kmt2c Δ/Δ GMPs (Figure 5C).”
BackgroundRivaroxaban attenuates neutrophil maturation in the bone marrow niche
Schneckmann, R., Döring, M., Gerfer, S., Gorreßen, S., Heitmeier, S., Helten, C., Polzin, A., Jung, C., Kelm, M., Fender, A. C., et al. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-01001-5 · Cited by 7
“Importantly, it has been reported that proliferation of intermediate myeloid progenitors is essential before differentiation takes place [57].”
Zhu, Y., Li, J., Li, Q., & Pang, Y. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.05.015 · Cited by 7
Tumor Suppressor Genes in Myeloid Differentiation and Leukemogenesis
Britschgi, C., & Fey, M. F. (2009) · Future Oncology · doi:10.2217/14796694.5.2.245 · Cited by 8
Bejan, V., Drăgoi, E.-N., Curteanu, S., Scripcariu, V., & Filip, B. (2022) · Healthcare · doi:10.3390/healthcare10081425 · Cited by 6
“Based on animal studies, these cells mature in the bone marrow, and only 1–2% will become circulating cells [48].”
BackgroundSadria, M., Layton, A. T., Goyal, S., & Bader, G. D. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100819 · Cited by 21
“9,22,35,36 Fatecode learned a latent node that, when perturbed, simultaneously increases the monocyte population and decreases erythrocytes and granulocytes (Figure 4B).”
The T-Cell Oncogene Tal2 Is a Target of PU.1 and Upregulated during Osteoclastogenesis
Courtial, N., Mücke, C., Herkt, S. C., Kolodziej, S., Hussong, H., & Lausen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076637 · Cited by 5
“regulator of myeloid differentiation [38].”
(2018) · doi:10.22099/mbrc.2018.27625.1297
“Hematopoiesis is an extremely arranged interaction of lineage-specific transcription factors that moving pluripotent precursor cells to the differentiated mature blood cells [5].”
BackgroundCampana, D., & Pui, C. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00096-5 · Cited by 6
Amin, A. R. (2012) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.s8-002 · Cited by 7
“Adoptive transfer of tumor antigen-specific CD8+ T cells in mice devoid of C/ EBPβ in myeloid cells gave rise to promising therapy in established tumors [49-51].”
BackgroundHijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer
Marinescu, G., & Feng, Y. (2026) · Molecular Oncology · doi:10.1002/1878-0261.70241 · Cited by 7
“Additional regulators include PU.1 (SPI1), GFI1, LEF1, C/EBP e and RUNX1 further coordinate lineage fidelity and maturation timing [50 – 55].”
Hyperéosinophilies et syndromes hyperéosinophiliques
Kahn, J., Legrand, F., Capron, M., & Prin, L. (2011) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(11)52510-5 · Cited by 10
Stochastic multistationarity in a model of the hematopoietic stem cell differentiation network
Al-Radhawi, M. A., Kumar, N. S., Sontag, E. D., & Vecchio, D. D. (2018) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc.2018.8619300 · Cited by 6
“The classical hierarchical treelike model of blood cells (hematopoiesis) describes the differentiation of HSCs into progenitor cells which have the ability to further differentiate into committed cells [12], [13], [14].”
Łączak, M., Kuczyńska, M., Grygier, J., Andrzejewska, D., Grochowska, W., Gulaczyk, H., & Lewandowski, K. C. (2022) · Hematology in Clinical Practice · doi:10.5603/hcp.a2021.0013 · Cited by 6
Lee, J., Kwon, C.-S., Jeon, B.-E., Kim, W. R., Lee, D. H., Koh, S., Kim, H., & Kim, S. (2022) · Genes · doi:10.3390/genes13050883 · Cited by 5
Lineage switch from lymphoma to myeloid neoplasms: First case series from a single institution
Yang, W., Xie, S., Li, Y., Wang, J., Xiao, J., Huang, K., Wang, X., Wu, Y., Ma, L., & Nie, D. (2022) · Open Medicine · doi:10.1515/med-2022-0521 · Cited by 5
“Although studies have found that cell fate regulators, cytokine profiles, and treatment modalities can play a role in lineage switch, the mechanism of the process remains unclear [3,4].”
BackgroundWouters, B. J., Koss, C., & Delwel, R. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.10.006 · Cited by 5
Dual role of C/ EBP α as an activator and repressor of Gαi2 gene transcription
Xu, J., Kawai, Y., & Arinze, I. (2013) · Genes to Cells · doi:10.1111/gtc.12102 · Cited by 5
Leukemias, Lymphomas, and Other Related Disorders
Zhang, Y., & Rowley, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00079-3 · Cited by 7
Lee, S., Kivimäe, S., & Szoka, F. C. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.08.007 · Cited by 6
“To increase the rate of differentiation, we identified IRF8 as a transcription factor that is upregulated during MF differentiation.(30) By expressing 4-OHT-induced IRF8-ERT, we hypothesized that we could bypass the time required for IRF8 to be endogenously expressed and increase the differentiation rate of the HDP.”
BackgroundZhang, M.-M., Liu, N., Zhang, Y.-L., Rong, B., Wang, X.-L., Xu, C., Xie, Y.-Y., Shen, S., Zhu, J., Nimer, S. D., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0398-8 · Cited by 5
Horitani, K., Iwasaki, M., Kishimoto, H., Wada, K., Nakano, M., Park, H., Adachi, Y., Motooka, D., Okuzaki, D., & Shiojima, I. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00261.2021 · Cited by 8
Shafik, R. E., Hassan, N. M., El-Meligui, Y. M., & Shafik, H. E. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.3.609 · Cited by 6
Fok I cleavage–inhibition strategy for the specific and accurate detection of transcription factors
Gao, T., Wang, L., Zhu, J., Zhu, D., & Jiang, W. (2015) · Talanta · doi:10.1016/j.talanta.2015.05.032 · Cited by 6
Patel, A. A., & Yona, S. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0001218.pub2 · Cited by 6
Martín, G. M., Santoro, F., Blanco, E., Figueroa, G. P. G., Dily, F. L., Frigè, G., Vidal, E., Mugianesi, F., Ballaré, C., Gutiérrez, A., et al. (2022) · Genes & Development · doi:10.1101/gad.349115.121 · Cited by 5
Üresin, N., Petrosius, V., Aragon-Fernandez, P., Furtwängler, B., Schoof, E. M., & Porse, B. T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.03.592307 · Cited by 7
Epiblast-derived CX3CR1+ progenitors generate cardiovascular cells during cardiogenesis
Cho, K.-W., Andrade, M., Khodayari, S., Lee, C., Bae, S., Kim, S., Kim, J. E., & Yoon, Y. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00488-z · Cited by 4
“…mesoderm to hematopoietic stem cells), Cebpa (a transcription factor required for differentiation of hematopoietic stem cells to granulocyte-monocyte progenitors), and Irf8 (a transcription factor required for differentiation of monoblasts to macrophages) (Rosenbauer and Tenen, 2007) via qRT-PCR.”
Zhou, Z., Li, X., Wang, Y., Liang, L., Wang, C., Sun, Y., Wu, D., & Qiu, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-69996-8 · Cited by 5
“Among these, PU.1 emerged as a key focus due to its established role as a master regulator of macrophage homeostasis 40 .”
Zhu, M., Zhu, J., Zhu, Z., Yang, Y., Dai, J., Li, H., Li, N., & Huang, J. (2025) · Communications Biology · doi:10.1038/s42003-025-08257-8 · Cited by 4
“…in hematopoietic stem/progenitor cells (HSPC) clusters, CEBPA and SPI1 (PU.1) in myeloid lineage, and GATA2 and MYC in erythroid progenitor cells 25,26 . eMut detects and interprets single-cell non-coding mutations based on scATAC-seq data The current mutation detection pipelines using…”
Hu, X., Cai, J., Zhu, J., Lang, W., Zhong, J., Zhong, H., & Chen, F. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109409 · Cited by 4
Herrera-Uribe, J., Lim, K., Byrne, K. A., Daharsh, L., Liu, H., Corbett, R. J., Marco, G., Schroyen, M., Koltes, J. E., Loving, C. L., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1107462 · Cited by 4
“Additionally, we were able to find MSTFs such as SPI1, CEBPB and CEBPA, which also have been reported as highly expressed in human and mice myeloid lineages (Rosenbauer and Tenen, 2007; Mildner et al., 2017; Braun et al., 2019).”
BackgroundYuan, R., Ao, P., Wang, G., & Su, H. (2017) · Scientia Sinica Vitae · doi:10.1360/n052016-00309 · Cited by 3
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Zjablovskaja, P., Daněk, P., Adamcova, M. K., & Alberich-Jordà, M. (2018) · Journal of Visualized Experiments · doi:10.3791/57033 · Cited by 4
Qi, X., Zhang, X., Liu, X., Tang, W., Dai, J., Chen, A., Lin, Q., Zhu, T., & Li, J. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115459 · Cited by 4
Nin, D. S., Li, F., Visvanathan, S., & Khan, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00210 · Cited by 4
Nin, D. S., Ali, A. B., Okumura, K., Asou, N., Chen, C.-S., Chng, W. J., & Khan, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070891 · Cited by 4
“Balanced transcriptional control maintained by the coordinated actions of co-activator and co-repressor proteins and sequence specific transcriptional factors play an important role in the normal growth and development of cells in the hematopoietic system [1].”
BackgroundRole of microRNAs in hematological malignancies
Fatica, A., & Bozzoni, I. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.32 · Cited by 5
Khateb, M., Fourier, N., Barnea-Yizhar, O., Ram, S., Kovalev, E., Azriel, A., Rand, U., Nakayama, M., Häuser, H., Gepstein, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156812 · Cited by 4
“Transcription factors play key roles in this differentiation process through the regulation of a characteristic set of lineage-specific target genes [1 – 4].”
Identification of drugs for leukaemia differentiation therapy by network pharmacologyPreprint
Christodoulou, E. G., Lee, L. M., Lee, K. L., Fung, T. K., So, C. W. E., Petretto, E. G., Ong, S. T., & Rackham, O. J. L. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/676106 · Cited by 4
Chao, Y., Xiang, Y., Xiao, J., Zhang, S., Zheng, W., Wan, X., Zhuoxuan, L. I., Gao, M., Wang, G., Chen, Z., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.02.505700 · Cited by 4
Myeloid diversity in tumors: Shaped by genes, location, and time
Nogales-Pons, M., Munárriz-Paños, M., Aceña-Gonzalo, T., & Casanova-Acebes, M. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20252267 · Cited by 3
Blood vessel-resident macrophages safeguard blood and vessel integrity in zebrafish
Weijts, B. G. M. W., Demmers, J., & Robin, C. (2026) · Nature Immunology · doi:10.1038/s41590-026-02481-y · Cited by 4
“Macrophage development depends on spi-1 proto-oncogene b ( spi1b ) ( PU.1 ) 22 and downstream-acting interferon regulatory factor 8 ( irf8 ) 23 .”
Jassinskaja, M., & Hansson, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.824098 · Cited by 3
“Extracellularly, adult myelopoiesis is strongly stimulated by cytokines such as granulocyte-colony stimulating factor (G-CSF), macrophage (M)-CSF and interleukin (IL)-6 (Nakamura et al., 2004; Rosenbauer and Tenen, 2007).”
BackgroundBender, A., Boydere, F., Jayavelu, A. K., Tibello, A., König, T., Aleth, H., zu Hörste, G. M., Vogl, T. J., & Rosenbauer, F. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00295-y · Cited by 6
“A central TF involved in controlling hematopoietic precursors, especially of the myeloid lineage, is PU.1 (Rosenbauer and Tenen, 2007).”
Self-citationWang, F., Gonzalez, L., Lian, Q., Hammond, C. A., Lau, Y. Y. M., Simons, B. D., Hirst, M., & Eaves, C. J. (2025) · Blood · doi:10.1182/blood.2024026936 · Cited by 3
Kharas, M. G., & Daley, G. Q. (2010) · Genes & Cancer · doi:10.1177/1947601911407327 · Cited by 4
“Modifications of myeloid-specific transcription factors such as CCAAT/enhancer binding protein (CEBP) and PU1 are known contributors to leukemia.(106,107) Besides these transcription factors, RNA binding proteins can also regulate leukemia progression as shown in a recent study that identified the RNA binding protein…”
BackgroundSasaki, T., Tanaka, Y., Kulkeaw, K., Yumine-Takai, A., Tan, K. S., Nishinakamura, R., Ishida, J., Fukamizu, A., & Sugiyama, D. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9668-2 · Cited by 4
“In myeloid differentiation, expression of specific transcription factors reportedly reflects cell lineage- and stagerestricted patterns [24].”
BackgroundOrigin and Development of Microglia
Patro, N., & Patro, I. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_7 · Cited by 3
Role of B-Cell Lymphoma/Leukemia 11A in Normal and Malignant Hematopoiesis
Zhang, H., Zeng, J., Zhang, F., Liu, J., & Liang, L. (2025) · Biology · doi:10.3390/biology14010026 · Cited by 5
C/EBPα, do not forget your TIP60
So, C. W. E., & van der Reijden, B. A. (2008) · Leukemia · doi:10.1038/leu.2008.16 · Cited by 3
DNMT3A (DNA (cytosine-5-)-methyltransferase 3 alpha)
Kuo, Y., Li, L., & Tien, H. (2013) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/51421 · Cited by 3
“DNMT3A mutations frequently detected in 7-29% of AML patients.”
BackgroundInfluentialHasemann, M. S., Schuster, M. B., Frank, A.-K., Theilgaard‐Mönch, K., Pedersen, T. Å., Nerlov, C., & Porse, B. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038841 · Cited by 4
“In particular, many transcription factors have been shown to modulate key events in differentiation and proliferation and their function in hematopoiesis has been investigated thoroughly through the examination of knockout mice [2].”
BackgroundZhang, X., Yang, Y., Wei, Y., Zhao, Q., & Lou, X. (2022) · Development · doi:10.1242/dev.200919 · Cited by 3
Core binding factor leukemia hijacks T-cell prone PU.1 antisense promoterPreprint
van der Kouwe, E., Heller, G., Czibere, A., Castilla, L. H., Delwel, R., Ruscio, A. D., Ebralidze, A. K., Forte, M., Kazianka, L., Kornauth, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.29.120857 · Cited by 3
Self-citationEffective leukemia-to-granulocyte induction by a cocktail of RUNX1, SPI1 and CEBPE
Xiang, G., Zhu, P., Zhang, L., Yu, S., Jiang, F., Wang, S., Wang, J., Dai, Y., Wang, S., Tan, Y., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217820 · Cited by 2
Kawano, Y., Katsuya, N., Moriyama, M., Ohki, S., Kitajima, Y., & Yasuda, T. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07930-4 · Cited by 3
“In this classical model, HSCs give rise to multipotent progenitors (MPPs), which further differentiate into myeloid lineages including common myeloid progenitors (CMPs), and lymphoid lineages including common lymphoid progenitors (CLPs) through lymphoid-primed multipotent progenitors (LMPPs) [1, 2].”
Oshima, M., Takayama, N., Nakajima-Takagi, Y., Shinoda, D., Itokawa, N., Kurosawa, S., Kaito, S., Kamiya, T., Yamada, Y., Andoh, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65753-5 · Cited by 2
“The CEBP family is a key regulator of myeloid differentiation, with C/EBP α being particularly critical for driving myelopoiesis 39 – 41 .”
Dev, S., Wang, Y., Jung, M., Ma, Y., Mani, S., Kabin, E., Yuda, R. A. A., Dong, Y., Ralle, M., Hamilton, J. P., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.116955 · Cited by 2
“25,27 To verify that downregulation in CEBP ε is also observed in Atp7b ΔMyeloid neutrophils, we isolated neutrophils from the ex vivo differentiated BM at 10 weeks.”
Effect and Mechanism Analysis of Pig FUT8 Gene on Resistance to Escherichia coli F18 Infection
Wu, L., Wang, Y., Wu, S., Wu, Z., & Bao, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314713 · Cited by 3
“During granulocyte formation, C/EBPα regulates differentiation at several steps, including the transition from common myeloid progenitor cells to granulocyte-macrophage progenitor cells [50].”
BackgroundMis-expression of GATA6 re-programs cell fate during early hematopoiesis
Audiger, C., Laâbi, Y., Nie, J., Gibson, L., Wilson-Annan, J., Brook-Carter, P. T., Kueh, A. J., Harris, A. W., Naik, S. H., Nutt, S. L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114159 · Cited by 2
Okamoto, R., & Koeffler, H. P. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10088-5 · Cited by 2
He, Y. J., Li, X. J., Wang, D., Zhang, E., Hu, Y., Wang, W., Huang, R., & Xiao, R. (2014) · Journal of International Medical Research · doi:10.1177/0300060514540630 · Cited by 3
Hosseinpour, B., Bakhtiarizadeh, M. R., Mirabbassi, S. M., & Ebrahimie, E. (2014) · Gene · doi:10.1016/j.gene.2014.07.069 · Cited by 2
“Transcription factors have been discovered to be the key targets of mutation in acute myeloid leukemia (AML) (Rosenbauer and Tenen, 2007), such as the CCAAT enhancer binding protein alpha (C/EBPα) or E2F3 (Pulikkan et al.”
BackgroundInfluentialCEBPA-CEBPG axis as a novel promising therapeutic target in acute myeloid leukemia
Lou, Y. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.191 · Cited by 3
Epigenetic regulation of cellular and cytomegalovirus genes during myeloid cell development
Liu, X., Hummel, M., & Abecassis, M. M. (2017) · Internal Medicine Review · doi:10.18103/imr.v3i3.385 · Cited by 3
“1 protein, encoded by Spi1 gene, is required for generation of common myeloid progenitors (CMPs) from hematopoietic stem cells (HSCs) and formation of the myeloid transcription network [18, 19].”
BackgroundHematological Findings in Non-Treated and γ-Irradiated Mice Deficient for MIC-1/GDF15
HOFER, M., Hoferová, Z., Remšík, J., Nováková, M., Procházková, J., Fedr, R., Kohoutek, J., Dušek, L., Hampl, A., & Souček, K. (2018) · Physiological Research · doi:10.33549/physiolres.933810 · Cited by 2
Wu, N., Li, R., Meng, Z., Nie, M., Chen, Q., He, B., Deng, Z., & Yin, L. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3910 · Cited by 2
Molecular Basis of Lymphoid and Myeloid Diseases
Biggs, J. R., & Zhang, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00016-x · Cited by 2
Grimwade, D. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511760273.009 · Cited by 2
Molecular pathogenesis of leukemia and leukemic stem cells (LSCs)
Kizaki, M. (2018) · International Journal of Hematology · doi:10.1007/s12185-018-2550-z · Cited by 2
The Histone Chaperone CAF-1 Sustains Myeloid Lineage IdentityPreprint
Guo, Y., Ji, F., Murn, J., Frankhouser, D. E., Blanco, M. A., Chiem, C., Jang, M., Sadreyev, R. I., Rockne, R. C., Sykes, D. B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.22.350447 · Cited by 2
“This is consistent with the known role of C/EBPα as a master regulator of GMP differentiation(Pundhir et al., 2018, Rosenbauer and Tenen, 2007).”
BackgroundResultThe epigenetic eraser LSD1 lies at the apex of a reversible erythroid to myeloid cell fate decisionPreprint
Yu, L., Myers, G., Ku, C.-J., Schneider, E., Wang, Y., Singh, S. A., Jearawiriyapaisarn, N., White, A. D., Moriguchi, T., Khoriaty, R. N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.13.426552 · Cited by 2
“PU.1 is a well characterized myeloid transcription factor(Laslo et al., 2006; Rosenbauer and Tenen, 2007; Scott et al., 1994), and transcriptional activation of Pu.1 is regulated by RUNX1 in HSPC(Willcockson et al., 2019).”
Choi, H., Byeon, G., Park, H., Park, J., Lim, S., & An, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.01.748703 · Cited by 2
Welte, T., Mai, J., Zhang, Z., Tian, S., Zhang, G., Xu, Y., Zhang, L., Chen, S.-S., Wang, T., & Shen, H. (2021) · iScience · doi:10.1016/j.isci.2021.103349 · Cited by 2
“…GSEA study revealed similarity of T1-binding tumor-infiltrating cells with several types of AML and CML. Similar as in MDSCs, blockage of differentiation is a hallmark feature of AML and CML (Chang et al., 2007; Chopra and Bohlander, 2019; Rosenbauer and Tenen, 2007; Terstappen et al., 1992).”
BackgroundAwasthi, D. K. (2023) · Clinical Case Reports and Studies · doi:10.59657/2837-2565.brs.23.034 · Cited by 1
Kayabaşı, Ç., & Gündüz, C. (2023) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2023.2236143 · Cited by 1
“[37] Our previously published results indicated that PI3K/mTOR inhibition caused C/ EBP transcriptional activation in LSC, but not in HSC. [16] Consistently, in the present study, we found that UCA1 , SNHG5 , NEAT1 , GAS5 , and SNHG4 regulations were specific to LSC; expression levels were stable…”
ResultFamilial acute myeloid leukemia due to a novel germline CEBPA pathogenic variant – a case report
Gava, F. M., Catto, L. F. B., Valera, E. T., dos Reis, M. B. F., Pintão, M. C. T., Chauffaille, M. D. L., Ramos, F. S. D., Scrideli, C. A., & de Figueiredo‐Pontes, L. L. (2024) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2024.07.004 · Cited by 1
Metadata
- Authors
- Rosenbauer, F., & Tenen, D. G.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 105-117
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1980860344
- Cited by
- 606
- References
- 142
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 17 · 2020: 21 · 2019: 28 · 2018: 30 · 2017: 45 · 2016: 31 · 2015: 42 · 2014: 38 · 2013: 43 · 2012: 27
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- Lymphoma Research Foundation
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- transcription factors, myeloid development, myeloid differentiation, myeloid leukemia, differentiation block, transcription factor dysregulation, cell fate regulation
- MeSH terms
- Animals, Cell Differentiation, Cell Transformation, Neoplastic, Hematopoietic Stem Cells, Humans, Leukemia, Myeloid, Transcription Factors, Mice, Knockout, Cell Lineage, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.